Tenaya Therapeutics
@TenayaThera
Followers
489
Following
23
Media
260
Statuses
338
Scaling new heights in the fight against heart disease.
South San Francisco, CA
Joined September 2021
Dr. Georgia Sarquella Brugada will present interim results from MyClimb, our natural history study of pediatric MYBPC3-associated #HCM at @escardio Congress in Madrid taking place from August 29 to September 1. #ESCCongress2025 #GeneTherapy
0
0
5
Tenaya is hosting an expert in the development of mass spectrometry-based proteomic techniques to discuss "Measuring Protein Expression in Cardiac Gene Therapy." The event will be broadcast live and available on the Tenaya website. Register below .
0
1
5
Next week, our CEO, Faraz Ali, will participate in a fireside chat at the Canaccord Genuity Growth Conference. Read our press release for more details: #TenayaTherapeutics #GeneTherapy #CanaccordGenuity
0
0
3
We reported second quarter financial results and provided business and program updates. Read more: #TenayaTherapeutics #GeneTherapy #HeartDisease
0
0
6
We are pleased to announce that we have received positive safety reviews from the independent DSMBs assigned to MyPEAK-1™ for TN-201 and RIDGE™-1 for TN-401 to advance the trials as designed.
0
0
9
Congrats to Alice Lara on her retirement from @SADSFoundation after a career of impact, compassion, and advocacy for those with SADS conditions. We look forward to working with her successor, Walker Frahm, and continuing this important mission.
0
1
5
June was full of connection and celebration at Tenaya! We volunteered at Samaritan House, celebrated #Pride Month with Drag Queen Bingo, and recharged as a team at our All Hands + Happy Hour. #TeamTenaya
0
0
4
Check out our CEO, Faraz Ali, in a recent #CommunityQuest video from @NPLB_org focused on heart disease. At Tenaya, we’re committed to advancing gene therapies that we hope someday allow us to better treat, prevent, and even cure heart disease. #HeartHealth.
Heart disease affects 120M+ Americans, impacting daily life and family health. #Biotech teams are working on new treatments. If you save for retirement or pay insurance premiums, you may be helping. 🎥 Watch to learn more. #CommunityQuest #FixInsurance #ProtectInnovation
0
0
6
Wishing you a happy Fourth of July! Grateful for our team and partners who share in our mission to improve the lives of people with heart disease. #FourthOfJuly
1
0
2
Natural history studies track how diseases progress and what affects outcomes. RIDGE™ is the largest natural history + seroprevalence study in adults with PKP2-associated #ARVC. It’s helping shape future potential gene therapies by informing clinical design and eligibility.
0
0
7
We’ve created novel promoters & regulatory elements to enable precise and robust expression of our therapeutic payloads. Learn more: #GeneTherapy #HeartDisease
0
0
3
#TeamTenaya recently attended #ASGCT25, where the global cell and gene therapy community came together to share progress and possibilities. At Tenaya, we’re focused on advancing genetic medicines for the heart and moving bold science toward real-world impact. #HeartHealth
0
1
7
ICYMI: Tenaya was pleased to partner with @HughCalkinsMD of @JohnsHopkins to present data from RIDGE™, the largest natural history study in adults with PKP2-related #ARVC. Despite standard-of-care medications and surgeries, patients continue to experience high disease burden.
0
1
8
What is protein expression?. The goal of #GeneTherapy is to deliver a working gene to allow the body to make the protein it may be lacking. Protein expression is the process by which cells make protein from instructions in genetic information.
0
1
9
If you're attending #ASGCT25 don’t miss our presentations on capsid engineering, gene editing, and manufacturing. Our researchers are laying the groundwork for future precision heart medicines. Full press release: #GeneTherapy #HeartHealth
1
1
6
We reported first quarter financial results and provided business and program updates. Read more: #TenayaTherapeutics #GeneTherapy #HeartDisease
0
1
3
Did you know Tenaya patient advocacy has a newsletter? We share quarterly updates about our arrhythmogenic right ventricular cardiomyopathy (#ARVC) and hypertrophic cardiomyopathy (#HCM) programs. Sign up for our newsletter by emailing us at: patient.advocacy@tenayathera.com
0
0
4
Interim data from RIDGE™, our natural history study of PKP2-associated #ARVC adults, indicate that patients experience a high arrhythmia burden and continued disease progression despite use of available treatments. #HRS2025 #HeartHealth
0
0
5
What is mRNA expression?. mRNA expression is an important indicator of how well a #GeneTherapy may be working. Level up your knowledge with our new resource From Gene to Protein: A Closer Look at Gene Therapy for Heart Conditions: #TenayaEducation
0
0
5
We’re looking forward to attending the Heart Rhythm Society’s annual Heart Rhythm Meeting from April 24-27!. Dr. Hugh Calkins will be presenting interim results from RIDGE™, a natural history and seroprevalence study of adults with PKP2-associated ARVC. #HRS2025 #HeartHealth
0
0
4